CERS Insider Trading Activity and SEC Form 4 Filings
CERS insider trading summary
Over the past 12 months, insiders at Cerus Corp (CERS) reported 22 sales worth $3.1M by 6 insiders and no open-market purchases on SEC Form 4. Net insider selling was $3.1M.
Latest CERS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Chrystal Jensen | Chief Legal Officer | Sell | $90K (30,000 @ $2.98) |
| Jul 16, 2026 | Vivek K Jayaraman | Chief Executive Officer | Sell | $53K (16,666 @ $3.16) |
| Jun 30, 2026 | Chrystal Jensen | Chief Legal Officer | Sell | $72K (24,329 @ $2.94) |
| Jun 30, 2026 | William Mariner Greenman | President and CEO | Sell | $300K (101,919 @ $2.94) |
| Jun 30, 2026 | Kevin Dennis Green | Chief Financial Officer | Sell | $99K (33,676 @ $2.94) |
| Jun 30, 2026 | Vivek K Jayaraman | Chief Operating Officer | Sell | $125K (42,359 @ $2.94) |
| Jun 9, 2026 | Eric Bjerkholt | Insider | Sell | $53K (20,454 @ $2.60) |
| May 29, 2026 | Vivek K Jayaraman | Chief Operating Officer | Sell | $50K (16,667 @ $3.00) |
| May 1, 2026 | Vivek K Jayaraman | Chief Operating Officer | Sell | $50K (16,667 @ $3.00) |
| Mar 12, 2026 | Richard J Benjamin | Chief Medical Officer | Sell | $169K (101,740 @ $1.66) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.